When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs

Alyssa Bilinski; Peter Neumann; Joshua Cohen; Teja Thorat; Katherine McDaniel; Joshua A Salomon

doi:10.1371/journal.pmed.1002397

When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs

PLoS Med. 2017 Oct 2;14(10):e1002397. doi: 10.1371/journal.pmed.1002397. eCollection 2017 Oct.

Authors

Alyssa Bilinski¹, Peter Neumann², Joshua Cohen², Teja Thorat², Katherine McDaniel³, Joshua A Salomon^{4

5}

Affiliations

¹ Interfaculty Initiative in Health Policy, Harvard University, Cambridge, Massachusetts, United States of America.
² Center for Evaluation and Risk in Health, Tufts Medical Center, Boston, Massachusetts, United States of America.
³ School of Social and Political Science, University of Edinburgh, Edinburgh, Scotland, United Kingdom.
⁴ Center for Health Policy and the Center for Primary Care and Outcomes Research, Stanford University, Stanford, California, United States of America.
⁵ Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.

Abstract

Potential cost-effective barriers in cost-effectiveness studies mean that budgetary impact analyses should also be included in post-2015 Sustainable Development Goal projects says Joshua Salomon and colleagues.

MeSH terms

Budgets
Cost-Benefit Analysis*
Global Health / economics*
Health Policy / economics*
Humans
Universal Health Insurance / economics*

Grants and funding

T32 HS000055/HS/AHRQ HHS/United States